{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:30:15Z","timestamp":1781893815398,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/jpet.123.001586","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T18:25:13Z","timestamp":1703183113000},"page":"670-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Melatonin Derivative ITH13001 Prevents Hypertension and Cardiovascular Alterations in Angiotensin II-Infused Mice"],"prefix":"10.1016","volume":"388","author":[{"given":"Marta","family":"Mart\u00ednez-Casales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Hernanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Gonz\u00e1lez-Carnicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T.","family":"Barr\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Briones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Michalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4017-5756","authenticated-orcid":false,"given":"Rafael","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefano","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-7666","authenticated-orcid":false,"given":"Ulf","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001586_bib1","first-page":"987","article-title":"The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension","volume":"7","author":"Ahmad","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1124\/jpet.123.001586_bib2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.bjp.0707575","article-title":"Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats","volume":"153","author":"Alvarez","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001586_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.106.115287","article-title":"Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats","volume":"321","author":"Alvarez","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001586_bib4","first-page":"136","article-title":"Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension","volume":"9","author":"Ambrosino","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1124\/jpet.123.001586_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2017.08.018","article-title":"Tert-butylhydroquinone attenuates oxidative stress and inflammation in hypothalamic paraventricular nucleus in high salt-induced hypertension","volume":"281","author":"Bai","year":"2017","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.123.001586_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1440-1681.12942","article-title":"Role of melatonin in blood pressure regulation: an adjunct anti-hypertensive agent","volume":"45","author":"Baker","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.123.001586_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2017.03.017","article-title":"The interplay between angiotensin II, TLR4 and hypertension","volume":"120","author":"Biancardi","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.123.001586_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/HYPERTENSIONAHA.109.133710","article-title":"Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress","volume":"54","author":"Briones","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/jpet.123.001586_bib9","doi-asserted-by":"crossref","first-page":"H193","DOI":"10.1152\/ajpheart.00802.2005","article-title":"Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats","volume":"291","author":"Briones","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.123.001586_bib10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s40265-016-0642-8","article-title":"Drug treatment of hypertension: focus on vascular health","volume":"76","author":"Cameron","year":"2016","journal-title":"Drugs"},{"key":"10.1124\/jpet.123.001586_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/biom10091211","article-title":"Melatonin\u2019s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease","volume":"10","author":"Chitimus","year":"2020","journal-title":"Biomolecules"},{"key":"10.1124\/jpet.123.001586_bib12","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/ajh.2009.186","article-title":"Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension","volume":"22","author":"Costa","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1124\/jpet.123.001586_bib13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00210-012-0798-z","article-title":"Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress","volume":"385","author":"da Costa","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.123.001586_bib14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/ijms22031064","article-title":"Emerging role of the inflammasome and pyroptosis in hypertension","volume":"22","author":"De Miguel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.123.001586_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/HYPERTENSIONAHA.122.19448","article-title":"Resolvin D2 attenuates cardiovascular damage in angiotensin II-induced hypertension","volume":"80","author":"D\u00edaz Del Campo","year":"2023","journal-title":"Hypertension"},{"key":"10.1124\/jpet.123.001586_bib16","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2147\/DDDT.S83144","article-title":"Effect of vitamin C on inflammation and metabolic markers in hypertensive and\/or diabetic obese adults: a randomized controlled trial","volume":"9","author":"Ellulu","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/jpet.123.001586_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10641963.2020.1836191","article-title":"Nrf2 inhibition induces oxidative stress, renal inflammation and hypertension in mice","volume":"43","author":"Farooqui","year":"2021","journal-title":"Clin Exp Hypertens"},{"key":"10.1124\/jpet.123.001586_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.phrs.2016.10.015","article-title":"NADPH oxidases and vascular remodeling in cardiovascular diseases","volume":"114","author":"Garc\u00eda-Redondo","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.123.001586_bib19","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1097\/HJH.0b013e32832d23e6","article-title":"Losartan and tempol treatments normalize the increased response to hydrogen peroxide in resistance arteries from hypertensive rats","volume":"27","author":"Garc\u00eda-Redondo","year":"2009","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.123.001586_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101100","article-title":"Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice","volume":"21","author":"Goh","year":"2019","journal-title":"Redox Biol"},{"key":"10.1124\/jpet.123.001586_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4330\/wjc.v6.i6.353","article-title":"Essential hypertension and oxidative stress: new insights","volume":"6","author":"Gonz\u00e1lez","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1124\/jpet.123.001586_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Griendling","year":"2021","journal-title":"Circ Res"},{"key":"10.1124\/jpet.123.001586_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardiores.2004.01.014","article-title":"Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin","volume":"62","author":"Hernanz","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.123.001586_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/CS20120651","article-title":"New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension","volume":"126","author":"Hernanz","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/jpet.123.001586_bib25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1476-5381.2012.01825.x","article-title":"Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function","volume":"166","author":"Hernanz","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001586_bib26","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1111\/bph.13117","article-title":"Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension","volume":"172","author":"Hernanz","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001586_bib27","unstructured":"Le\u00f3n R, Buendia I, Navarro E, Michalska P, Gameiro I, Egea J, Garc\u00eda-L\u00f3pez M, Garc\u00eda AG (2016) inventors. Compuestos derivados del acrilato de 3-alquiloamino-1H-indolilo y su uso en el tratamiento de enfermedades neurodegenerativas. Patent WO2016059269A1. 2016 Apr 21."},{"key":"10.1124\/jpet.123.001586_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10557-012-6415-z","article-title":"Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways","volume":"26","author":"Li","year":"2012","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/jpet.123.001586_bib29","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","article-title":"Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms","volume":"119","author":"Lombardi","year":"2009","journal-title":"Circulation"},{"key":"10.1124\/jpet.123.001586_bib5037458","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjp.0705380","article-title":"Extracellular L-arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall.","volume":"139","author":"MacKenzie","year":"2003","journal-title":"British journal of pharmacology"},{"key":"10.1124\/jpet.123.001586_bib30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.117.312647","article-title":"Hypertrophy regression with N-acetylcysteine in hypertrophic cardiomyopathy (HALT-HCM): a randomized, placebo-controlled, double-blind pilot study","volume":"122","author":"Marian","year":"2018","journal-title":"Circ Res"},{"key":"10.1124\/jpet.123.001586_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/HJH.0b013e32834f043b","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress","volume":"30","author":"Mart\u00edn","year":"2012","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.123.001586_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/ars.2011.4335","article-title":"Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension","volume":"18","author":"Mart\u00ednez-Revelles","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.123.001586_bib33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1124\/jpet.302.3.1295","article-title":"MT(2) melatonin receptors are present and functional in rat caudal artery","volume":"302","author":"Masana","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001586_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/antiox10091487","article-title":"Diosmetin ameliorates vascular dysfunction and remodeling by modulation of Nrf2\/HO-1 and p-JNK\/p-NF-\u03baB expression in hypertensive rats","volume":"10","author":"Meephat","year":"2021","journal-title":"Antioxidants"},{"key":"10.1124\/jpet.123.001586_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.123.001586_bib00787951","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/13894501113146660227","article-title":"Inducible nitric oxide synthase as a possible target in hypertension.","volume":"15","author":"Oliveira-Paula","year":"2014","journal-title":"Current drug targets"},{"key":"10.1124\/jpet.123.001586_bib36","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.3390\/ijms151017920","article-title":"Peripheral and central effects of melatonin on blood pressure regulation","volume":"15","author":"Pechanova","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.123.001586_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.CIR.104.2.191","article-title":"Prognostic significance of endothelial dysfunction in hypertensive patients","volume":"104","author":"Perticone","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/jpet.123.001586_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.freeradbiomed.2021.02.040","article-title":"Oxidative stress in cardiac hypertrophy: from molecular mechanisms to novel therapeutic targets","volume":"166","author":"Ramachandra","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.123.001586_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11739-011-0548-0","article-title":"Structural abnormalities of small resistance arteries in essential hypertension","volume":"7","author":"Rizzoni","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1124\/jpet.123.001586_bib40","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.CIR.0000095031.51492.C5","article-title":"Prognostic significance of small-artery structure in hypertension","volume":"108","author":"Rizzoni","year":"2003","journal-title":"Circulation"},{"key":"10.1124\/jpet.123.001586_bib41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/jcbfm.2011.139","article-title":"Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide","volume":"32","author":"Rodrigues","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.123.001586_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.phrs.2018.01.022","article-title":"Melatonin as an endogenous regulator of diseases: the role of autophagy","volume":"133","author":"Roohbakhsh","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.123.001586_bib43","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/01.hjh.0000358830.95439.e8","article-title":"Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats","volume":"27","author":"Simko","year":"2009","journal-title":"J Hypertens Suppl"},{"key":"10.1124\/jpet.123.001586_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/703175","article-title":"Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin","volume":"2014","author":"Simko","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1124\/jpet.123.001586_bib45","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1111\/jcmm.16504","article-title":"Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification","volume":"25","author":"Su","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.123.001586_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11906-996-0042-7","article-title":"Hypertension and the heart","volume":"2","author":"Susic","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1124\/jpet.123.001586_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14030534","article-title":"Oxidative stress in arterial hypertension (HTN): the nuclear factor erythroid factor 2-related factor 2 (Nrf2) pathway, implications and future perspectives","volume":"14","author":"Tanase","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1124\/jpet.123.001586_bib48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cjca.2020.02.081","article-title":"Oxidative stress: a unifying paradigm in hypertension","volume":"36","author":"Touyz","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1124\/jpet.123.001586_bib49","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1440-1681.2003.03930.x","article-title":"Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension","volume":"30","author":"Touyz","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.123.001586_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/jpet.110.174482","article-title":"MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries","volume":"336","author":"Tunstall","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001586_bib51","doi-asserted-by":"crossref","first-page":"H281","DOI":"10.1152\/ajpheart.00304.2008","article-title":"Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats","volume":"295","author":"Viel","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.123.001586_bib52","doi-asserted-by":"crossref","first-page":"R399","DOI":"10.1152\/ajpregu.00122.2017","article-title":"NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion","volume":"314","author":"Wang","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.123.001586_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-020-03409-0","article-title":"Immune mechanisms in arterial hypertension. Recent advances","volume":"385","author":"Wenzel","year":"2021","journal-title":"Cell Tissue Res"},{"key":"10.1124\/jpet.123.001586_bib54","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.123.001586_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105279","article-title":"Melatonin and regulation of autophagy: mechanisms and therapeutic implications","volume":"163","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.123.001586_bib56","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1073\/pnas.0402004101","article-title":"Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system","volume":"101","author":"Wu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001586_bib57","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.123.001586_bib58","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/cvr\/cvz312","article-title":"Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension","volume":"116","author":"Zhang","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.123.001586_bib59","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/en.2017-00752","article-title":"Nrf2 deficiency upregulates intrarenal angiotensin-converting enzyme-2 and angiotensin 1-7 receptor expression and attenuates hypertension and nephropathy in diabetic mice","volume":"159","author":"Zhao","year":"2018","journal-title":"Endocrinology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:25:54Z","timestamp":1743200754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022356524171972"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001586","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Melatonin Derivative ITH13001 Prevents Hypertension and Cardiovascular Alterations in Angiotensin II-Infused Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}